Patient Monitoring Devices Market Worth $71.1 billion | MarketsandMarkets™ [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
poised to reach $71.1 billion by 2029, growing at a CAGR of 8.0% from 2024 to 2029 according to a new report by MarketsandMarkets™. The expansion of the patient monitoring market is propelled by several synergistic factors, including increasing demand for wireless monitoring solutions, biosensors, the presence of key market players in developing regions, rising public-private investments to support for the clinical research, increasing geriatric patient population, and escalating chronic disorder prevalence. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=678 Browse in-depth TOC on "Patient Monitoring Devices Market" 215 - Tables 55 - Figures 250 - Pages Patient Monitoring Devices Market Scope: Report Coverage Details Market Revenue in 2024 $48.5 billion Estimated Value by 2029 $71.1 billion Growth Rate Poised to grow at a CAGR of 8.0% Market Size Available for 2022–2029 Forecast Period 2024–2029 Forecast U
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Global Drug-Eluting Stents Strategic Research Report 2024-2030: Biodegradable Polymers Represent Promising Developments, Offering the Potential for Enhanced Biocompatibility [Yahoo! Finance]Yahoo! Finance
- Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee [Yahoo! Finance]Yahoo! Finance
- Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneePR Newswire
- ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside? [Yahoo! Finance]Yahoo! Finance
- Global Penicillin Analysis Report 2024: Market to Grow by $2.82 Billion During 2023-2028, Driven by M&As, and Special Regulatory Designations Driving the Quality of Penicillin [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/29/24 - Form 8-K
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- ABT's page on the SEC website